Zeinab Kazemianpour: 1 Embryo, 2 Different Biopsy Strategies
Zeinab Kazemianpour, Clinical Embryologist at Nikan Hospital, shared on LinkedIn:
“One embryo, two different biopsy strategies.
Have you ever wondered why some embryos are biopsied on Day 3, while others are biopsied at the blastocyst stage?
On ‘Day 3’, a single blastomere can be removed from an early cleavage-stage embryo.
The main advantages are the early timing and relatively simple cell isolation.
However, the small amount of DNA and the possibility of mosaicism may sometimes lead to inconclusive or less representative results.
By ‘Day 5/6’, the embryo has reached the blastocyst stage.
Several ‘trophectoderm (TE) cells’ can be collected while leaving the ‘inner cell mass (ICM)’ untouched.
The larger sample provides more DNA for genetic testing, including ‘PGT-A, PGT-M and PGT-SR’.
After blastocyst biopsy, the embryo is usually vitrified while the genetic analysis is performed and can be transferred later in a frozen embryo transfer cycle.”

Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.
-
Nov 9, 2026, 18:08Strong Workplaces Start with Supported Employees – ESHRE
-
Nov 9, 2026, 18:00Nicole Haliday: Balancing Work and Fertility Treatment
-
Nov 9, 2026, 17:50How Employers Can Support Employees Facing Fertility Challenges – Ferring Pharmaceuticals
-
Nov 9, 2026, 17:41Esther Eleboh: IUI or IVF?
-
Nov 9, 2026, 17:36Asima Ahmad: Can Targeted Light Help More Embryos Develop During IVF?
-
Nov 9, 2026, 17:31Shweta Rajani Goswami: If Your IVF Has Failed, I May Still Tell You That Your First Doctor Did the Right Thing
-
Nov 9, 2026, 17:17Rajeev Agarwal: TSH 3.1 Before Pregnancy
-
Nov 9, 2026, 17:11Diana Kayal: Fertility Is a Conversation for 2
-
Nov 9, 2026, 17:01Lodovico Parmegiani: The Future of ART Laboratories May Already Be Moving Toward 100% ICSI
